- Home
- UBCP vs VRCA Comparison
UBCP vs VRCA Comparison
Compare UBCP & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | VRCA |
|---|---|---|
| Founded | 1902 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 88.0M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UBCP | VRCA |
|---|---|---|
| Price | $16.20 | $4.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 2.4K | ★ 57.0K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.58 | $94.44 |
| P/E Ratio | $23.48 | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $12.47 | $3.28 |
| 52 Week High | $17.34 | $9.82 |
Technical Indicators
Market Signals| Indicator | UBCP | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 37.75 |
| Support Level | $14.91 | $4.25 |
| Resistance Level | $16.88 | $6.22 |
| Average True Range (ATR) | 0.34 | 0.42 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 98.97 | 4.07 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.